Obtain liver tests before starting pioglitazone tablets. If abnormal, use caution when treating with pioglitazone tablets, investigate the probable cause, treat (if possible) and follow appropriately. Monitoring liver tests while on pioglitazone tablets is not recommended in patients without liver disease.
effects of pioglitazone hydrochloride on metabolic pathways of the liver. ACTION AND CLINICAL PHARMACOLOGY. Mechanism of Action. Pioglitazone
The risk of liver toxicity appears to be significantly lower with pioglitazone, but several case reports exist for both pioglitazone and rosiglitazone
Acute toxicity of pioglitazone has been associated with ventricular hypertrophy with congestion of the liver and kidney in mice 10. As a result of the reported associated toxicity observed with thiozolidinediones, the use of pioglitazone in the management of type 2 diabetes and the paucity of report on sub-chronic toxicity of pioglitazone.
pioglitazone in all patients. Therapy with pioglitazone should not be initiated in patients with increased baseline liver enzyme levels (ALT 2.5 X upper limit of normal) or with any other evidence of liver disease. Following initiation of therapy with pioglitazone, it is recommended that liver enzymes be monitored
by SK Saha 2024 Cited by 5Biochemical alterations and liver toxicity analysis with pioglitazone in healthy subjects ; Journal. Drug and Chemical Toxicology ; Volume. 36
Pioglitazone (as HCl) 15mg, 30mg, 45mg; tabs. Pharmacological Class Pioglitazone decreases insulin resistance in the periphery and in the liver
Liver Toxicity Knowledge Base (LTKB). Drug Induced Liver Injury Rank pioglitazone, 3, Warnings and precautions, Less-DILI-Concern, 1.
The liver toxicity associated with troglitazone is likely not a class effect. 32 In a review of 13 double blind studies, pioglitazone was associated with ALT elevation (3 ULN) in 0.26% of 1526 patients as opposed to 1.91% of 2510 patients receiving troglitazone. 33 ALT levels 10 ULN was not observed in the pioglitazone group.
Comments